This is an archived webpage for the 2022 Annual Meeting.
View the up-to-date information for the 2024 Annual Meeting.
View the up-to-date information for the 2024 Annual Meeting.
DCIS Controversies
Surgery, Adjuvant Therapy and Future Treatment Strategies
Wednesday, April 6
8:00 AM–3:00 PM
8:00 AM–3:00 PM
Course Moderators: E. Shelley Hwang, MD, MPH, FACS; Theresa Schwartz, MD, MS, FACS
Faculty: Brian Czerniecki, MD, PhD, FACS; E. Shelley Hwang, MD, MPH, FACS; Seema Khan, MD, FACS; Marc Ryser, PhD, MSc; Theresa Schwartz, MD, MS, FACS; Susie Sun, MD; Shawna Willey, MD, FACS
Course Description:
In this course, we will discuss the current multi-disciplinary management recommendations for DCIS as well as cutting edge technologies and ongoing clinical trials. Our panel of experts will review all facets of the disease and its treatment options to give the audience a well-rounded, comprehensive understanding of DCIS.
Course Objectives:
At the conclusion of this course, participants should be able to:
- Understand the epidemiology of DCIS
- Understand the importance of tumor biology and molecular testing in DCIS
- Describe the indications for adjuvant radiation and endocrine therapy in DCIS
- Be able to explain the current surveillance trials and future treatment strategies for DCIS, including their clinical implications
CME Information:
The American Society of Breast Surgeons designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Agenda:
| 7:00 AM | Check-in and Breakfast
|
| 8:00 AM | Welcome and Introduction
E. Shelley Hwang, MD, MPH, FACS; Theresa Schwartz, MD, MS, FACS |
| 8:05 AM | Epidemiology of DCIS—Defining Overtreatment
Marc Ryser, PhD, MSc |
| 8:45 AM | Imaging and Pre-operative Workup for DCIS
Theresa Schwartz, MD, MS, FACS |
| 9:15 AM | Panel Discussion with Q&A
|
| 9:45 AM | Break
|
| 10:00 AM | Margin Consideration and Adjuvant Radiation for DCIS
Susie Sun, MD |
| 10:30 AM | Endocrine Therapy for DCIS
Seema Khan, MD, FACS |
| 11:00 AM | Personalized Treatment & Molecular Testing for DCIS
Shawna Willey, MD, FACS |
| 11:30 AM | Vaccine Therapy for DCIS
Brian Czerniecki, MD, PhD, FACS |
| 12:00 PM | Panel Discussion with Q&A
|
| 12:30 PM | Lunch
|
| 1:30 PM | Active Surveillance Trials for DCIS
E. Shelley Hwang, MD, MPH, FACS |
| 2:00 PM | Survivorship after DCIS Treatment
Theresa Schwartz, MD, MS, FACS |
| 2:30 PM | Panel Discussion with Q&A
|
| 3:00 PM | Adjourn
|
